Miro1 Impairment in a Parkinson’s At-Risk Cohort

There is a lack of reliable molecular markers for Parkinson’s disease (PD) patients and at-risk individuals. The detection of the pre-symptomatic population of PD will empower more effective clinical intervention to delay or prevent disease onset. We have previously found that the mitochondrial prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, David, Bharat, Vinita, Conradson, Devon M., Nandakishore, Pawan, Wang, Xinnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381147/
https://www.ncbi.nlm.nih.gov/pubmed/34434090
http://dx.doi.org/10.3389/fnmol.2021.734273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381147/
https://www.ncbi.nlm.nih.gov/pubmed/34434090
http://dx.doi.org/10.3389/fnmol.2021.734273

Ejemplares similares